1st Edition
Cancer Vaccination and Challenges Volume 1: Strategies for Therapeutic Cancer Vaccine Development
1. Cancer Vaccines: Types, Mechanisms, and Recent Developments
Lucy Mohapatra, Deepak Mishra, Alok Shiomurti Tripathi, and Sambit Kumar Parida
2. Strategies to Develop Cancer Vaccines
J. Patel Dhaval, A. Chaudhary Sunita, B. Chaudhary Ankit, and Bhupendra G.Prajapati
3. Role of Tumor Antigens for Cancer Vaccine Development
Himanshu Sharma, Rashmi Pathak, Neetu Sachan, and Phool Chandra
4. DNA-Based Cancer Vaccine: Advancements and Challenges
Sagar Pandav, Vipul P. Patel, Arde Gayatri, and Bhupendra Prajapati
5. RNA-Based Cancer Vaccines: Advancements and Challenges
Palak A. Shah, Rashmi A. Shukla, Mehul R. Chorawala, Nimisha P. Kakadia, Bhupendra Prajapati, and Shrikalp S. Deshpande
6. Utilization of Microbial Genes as a Vaccine Against Cancer
Garima Varshney, Rishabha Malviya, Sonali Sundram, and Dhanalekshmi Unnikrishnan Meenakshi
7. Utilization of Protein and Peptides as Cancer Vaccines: Advancements and Challenges Assessment of Ethnomedical Plants: Shiwalik Hills, Himanchal Pradesh, India
Patel Gayatri and Patel Priya
8. Stem Cell-Based Cancer Vaccines as Promising Immunotherapy: Current Progress and Challenges
Mehul R. Chorawala, Humzah Postwala, Yesha Shah, Palak A. Shah, Bhupendra Prajapati, and Vishvas N. Patel
9. Preventive Cancer Vaccine
Sachin P. Bhatt, Avani N. Joshi, and Bhupendra G. Prajapati
10. Providing Cognitive Platforms for the Effectiveness of Cancer Vaccines
Zahra Alidousti Shahraki and Mohsen Aghabozorgi Nafchi
11. Survival Data and Therapeutic Outcomes of Cancer Vaccines
Patel Priya, Prajapati Bhupendra, and Patel Gayatri
12. Regulatory Considerations for Cancer Vaccines Development
Shivani N. Jani, Hitesh B. Katariya, and Bhupendra G. Prajapati
Biography
Rishabha Malviya, PhD, has 11 years of research experience and is presently working as Associate Professor of Pharmacy, School of Medical and Allied Sciences, Galgotias University, India. He has authored over 150 research and review papers and book chapters and edited 13 books to date. He has been included in the World’s Top 2% Scientists list by Elsevier BV and Stanford University. He is a reviewer, editor, and editorial board member of more than 50 national and international journals.
Bhupendra Prajapati, PhD, is a Professor of Pharmaceutics at Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, India. He has more than 20 years of academic and research experience and has published more than 100 research and review papers, edited three books, and authored 20 book chapters on novel drug delivery. He has also published two Indian patents and has three applications under evaluation. He is a reviewer for three high-impact journals and is on the editorial boards of several scientific journals.
Sonali Sundram, PhD, is Assistant Professor in the School of Medical & Allied Sciences at Galgotias University, India. Previously, she was a research scientist on a project of the Indian Council of Medical Research (ICMR) at King George’s Medical University, Lucknow, India. After that, she joined BBDNIIT (Babu Banarasi Das Northern India Institute of Technology), Lucknow. She has authored or edited 14 books and has organized several national and international seminars, conferences, and workshops. She has more than eight patents, both national and international, to her credit
“A comprehensive guide to cancer vaccine research. . . . cover[s] every aspect of cancer immunology and vaccine development . . . and explores the most successful and promising approaches by incorporating the latest studies on preventive and therapeutic cancer vaccination. The book offers up-to-date information on various topics, including tumor antigens for cancer vaccines, strategies, approaches, advancements, difficulties, and challenges in vaccine development for cancer treatment. Recent advances in DNA and RNA-based vaccines for cancer prevention and treatment are thoroughly discussed in this volume. This compendium enables researchers and practitioners to easily access the comprehensive concept of cancer vaccines and their implications in healthcare. . . . An essential resource in disseminating the vast and expanding literature on cancer immunization and vaccine development.”
—From the Foreword by Harish Padh, Former Vice-Chancellor, Sardar Patel University, Vallabh Vidyanagar, Anand, Gujarat, India; Former Director, B. V. Patel Pharmaceutical Education and Research Development (PERD), Ahmedabad, Gujarat, India
